Embecta (FRA:JX7) Buildings And Improvements : €111 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Buildings And Improvements?

Embecta's quarterly buildings and improvements declined from Sep. 2023 (€117 Mil) to Dec. 2023 (€112 Mil) and declined from Dec. 2023 (€112 Mil) to Mar. 2024 (€111 Mil).

Embecta's annual buildings and improvements increased from Sep. 2021 (€102 Mil) to Sep. 2022 (€125 Mil) but then declined from Sep. 2022 (€125 Mil) to Sep. 2023 (€117 Mil).

Embecta Buildings And Improvements Historical Data

The historical data trend for Embecta's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Buildings And Improvements Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Buildings And Improvements

101.03

102.34

124.94

116.66

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial											120.02	117.31	116.66	112.33	111.32

Embecta Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines